GlassScriptPhysician profile
Alex A Nourian
NPI 1891289245
$10,417.30
in general payments reported to CMS, 2019-2025
44 companies · $2,335 in 2025
The $2,335 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $419 · 2020: $139 · 2021: $330 · 2022: $1,374 · 2023: $3,434 · 2024: $2,387 · 2025: $2,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,266 · Travel and Lodging: $1,447 · Education: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,265.72 |
| Travel and Lodging | $1,446.62 |
| Education | $443.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,110.52 | 2020-2024 | Titan |
| Boston Scientific Corporation | $1,980.37 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml, General - Kidney Stone Disease |
| Abbvie INC. | $496.80 | 2023-2025 | |
| Medtronic, INC. | $492.88 | 2021-2023 | Interstim |
| Janssen Biotech, INC. | $458.47 | 2023-2025 | Erleada, Balversa, Akeega |
| Astellas Pharma US INC | $432.27 | 2024-2025 | Xtandi |
| Urogen Pharma, INC. | $389.32 | 2022-2025 | Jelmyto |
| Pfizer INC. | $339.56 | 2024-2025 | |
| Endo USA, INC. | $334.59 | 2024-2025 | Xiaflex |
| Procept Biorobotics Corporation | $315.46 | 2019-2025 | Aquabeam System |
| Blue Earth Diagnostics | $253.33 | 2019-2025 | Posluma |
| Janssen Scientific Affairs, LLC | $234.81 | 2022-2023 | Erleada |
| Myriad Genetic Laboratories, INC. | $216.10 | 2023-2025 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $207.01 | 2024-2025 | |
| Antares Pharma, INC. | $178.49 | 2024-2025 | Xyosted |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $160.90 | 2022-2025 | Barrigel |
| Telix Pharmaceuticals | $159.48 | 2023-2025 | Illuccix |
| 180 Medical, INC. | $143.67 | 2023-2024 | Gentlecath Glide |
| Progenics Pharmaceuticals, INC. | $131.71 | 2023-2025 | Pylarify |
| Verity Pharmaceuticals INC. | $120.27 | 2025 | Tlando |
| Urovant Sciences INC | $120.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $117.94 | 2022-2023 | |
| Photocure INC | $107.92 | 2020 | |
| Immunitybio, INC. | $81.15 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $76.97 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $70.31 | 2020-2024 | Xiaflex |
| Becton, Dickinson and Company | $69.88 | 2024 | Bard Urinary Drainage Bag |
| Axonics, INC. | $62.21 | 2023-2024 | Axonics, Bulkamid |
| Cycle Pharmaceuticals INC | $60.61 | 2025 | Venxxiva |
| Medtronic USA, INC. | $56.20 | 2019 | |
| Valencia Technologies Corporation | $48.27 | 2025 | Ecoin Device Kit |
| Clarus Therapeutics INC. | $46.31 | 2021 | |
| Sumitomo Pharma America, INC. | $42.34 | 2024-2025 | Gemtesa, Orgovyx |
| Laborie Medical Technologies Corp. | $40.51 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar, INC. | $38.43 | 2024-2025 | Eligard, Jatenzo |
| Vertex Pharmaceuticals Incorporated | $34.34 | 2024 | |
| Merck Sharp & Dohme LLC | $31.10 | 2024 | Lynparza |
| Novartis Pharmaceuticals Corporation | $30.80 | 2025 | |
| Myovant Sciences INC. | $29.14 | 2022 | |
| Caris Mpi, INC. | $24.32 | 2025 | Mi Cancer Seek |
| Olympus America INC. | $21.07 | 2025 | Uropass |
| Halozyme INC | $19.75 | 2023 | |
| Angiodynamics, INC. | $17.76 | 2025 | Nanoknife |
| Ferring Pharmaceuticals INC. | $13.71 | 2025 | Adstiladrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Nourian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.